
SIMULTANEOUSLY BOTH EXPRESSION OF LMP-1
AND METHYLATION OF E-CADHERIN:
MOLECULAR BIOMARKER IN STAGE IV OF
NASOPHARYNGEAL CARCINOMA PATIENTS Lao TD1, Truong PK1, Thieu HH1, Nguyen DH2, Nguyen MT3, Le TAH1,* *Corresponding Author: Associate Professor Thuy A.H. Le, Department of Pharmaceutical and Medical
Biotechnology, Ho Chi Minh City Open University, 35-37 Ho Hao Hon Street, Ho Chi Minh City,
Vietnam. Tel.: +84-905-784-471. E-mail: thuy.lha@ou.edu.vn page: 57
|
INTRODUCTION
A nasopharyngeal carcinoma (NPC) is a prevalent nasopharyngeal
malignant tumor with remarkable differences
in distribution that gravitates toward Southern Asia. Even
though many improvements in NPC therapy have been
achieved, the diagnosis at an advanced stage led to reducing
the success rate of treatment as well as the survival of
patients [1]. Thus, early screening and diagnosis represents
beneficial opportunities to increase the survival of patients
as well as the effects of nasopharyngeal cancer treatment.
Because of the nonspecific symptoms related to the early
stage of NPC as well as the deeply seated location of nasopharynx,
it leads to major obstacles to early screening of
NPC [2]. Therefore, effective biomarkers are truly needed
[3]. According to the etiology of NPC, a strong association
between the infection of Epstein-Barr virus (EBV), also
known as human γ-herpesvirus 4 (HHV4), and NPC has
been postulated [4-8]. In the stage of latency, the limited
latent genes are expressed, have been reported to play the
key role in nasopharyngeal tumorigenesis [9-11]. Among
them, the latent membrane protein 1 (LMP-1) gene, its
encoded protein, has profound effects on the proliferation
as well as the metastasis of NPC cells, resulting in the
highly invasive and malignant growth of nasopharyngeal
tumors [10]. In addition to the expression of LMP-1, the
establishment of an epigenetic change on the E-cadherin
gene, located on chromosome 16q22.1, which is responsible
for the main key mediator of cell-cell adhesion in
epithelial tissue, by the forming of E-cadherin/catenin
complex that is further linked to the actin cytoskeleton, is
likely to be a major contributing factor to the development
and metastasis of nasopharyngeal tumors [12,13]. Recent
growing evidence indicated that the hypermethylation, a
kind of epigenetic alteration of E-cadherin resulting in the
silence of its function, has been reported to play a key role in NPC development and metastasis [14-17]. Are there
any associations between the expression of LMP-1 and
meth-ylation of E-cadherin in NPC tumorigenesis? And,
emphatically, that is to determine whether a combination
of LMP-1 expression and methylation of E-cadherin could
be a significant molecular characteristic of nasopharyngeal
carcinomas, as well as it could be the potential biomarker
for NPC. To answer the issue mentioned above, the present
case-control study was designed to explore the relationship
in the expressions of LMP-1 and the hypermethylation of
E-cadherin in NPC tumor and non cancerous specimens
of Vietnamese population.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|